Objectives: The aim of the study was to calculate the prevalence rates and risk ofappearance of Dupuytrèn disease in diabetic patients with both type-1 (T1DM) andtype-2 diabetes (T2DM). Material and Method: 384 patients were analysed, ofwhich 47 had T1DM, 140 had T2DM and 197 were non-diabetic controls. Diabeticpatients were followed at the Clinical Center for Diabetes, Nutrition and MetabolicDisease of the Emergency Clinical County Hospital and Department of Dermatologyin Oradea, all of them having a diabetes duration of at least 5 years. Results and Conclusions: The risk of Dupuytrèn’s disease is over 4.5 times greater in patientswith type-2 diabetes. The risk of Dupuytrèn’s disease is 3-6 times greater in patientswith micro-vascular complications.
5. Conessa C. Contribution a l'etude des perturbations vasculaires dans la maladie de Dupuytren PhD Thesis Lyon 1981.
6. Heathcote JG Cohen H Noble J. Dupuytren’s disease and diabetes mellitus. Lancet i (8235): 1420 1981.
7. Arkkila PE Kantola IM Viikari JSRönnemaa T Vähätalo MA. Dupuytren's disease in type 1 diabetic patients: a five-year prospective study. Clin Exp Rheumatol 14: 59-65 1996.
8. Dupuytren G. Permanent retraction of the fingers produced by an affection of the palmer fascia. Lancet 22: 222-225 1834.
9. Melhorn JM Ackerman WE. Musculoskeletal disorders. In: Guides to the evaluation of disease and injury causation. Melhorn JM & Ackerman WE IIIrd (Eds). Am Med Assoc Press Chicago pp. 147-152; pp. 191-202 2007.
10. Geraci A Bianchi R Sanfilippo AD’Arienzo M. Dupuytren contracture in diabetic hand. Endocrin Stud vol. 1:e2 pp. 6 2011.
11. Jennings AM Milner PC Ward JD. Hand abnormalities are associated with the complications of diabetes in type 2 diabetes: Diabetic Med 6: 43-47
12. Gamstedt J Holm-Glad J Ohlson CGSundström M. Hand abnormalities are strongly associated with the duration of diabetes mellitus. JIntern Med 234: 189-193 1993.